2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide

C10H22N4O2 — CID 63578798

IUPAC2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide
SMILESCCCN(CC(=O)N(C)C)C(C)C(=O)NN
InChIInChI=1S/C10H22N4O2/c1-5-6-14(7-9(15)13(3)4)8(2)10(16)12-11/h8H,5-7,11H2,1-4H3,(H,12,16)
InChIKeyQPMAMINMUFVDPD-UHFFFAOYSA-N
MW230.31 g/mol
LogP-0.83
Rot. Bonds6

About 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide

2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide (PubChem CID 63578798) has the molecular formula C10H22N4O2 and a molecular weight of 230.31 g/mol. Its IUPAC name is 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide.

Molecular Properties

Compound Name2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide
PubChem CID63578798
Molecular FormulaC10H22N4O2
Molecular Weight230.31 g/mol
Exact Mass230.17
IUPAC Name2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide
SMILESCCCN(CC(=O)N(C)C)C(C)C(=O)NN
InChIInChI=1S/C10H22N4O2/c1-5-6-14(7-9(15)13(3)4)8(2)10(16)12-11/h8H,5-7,11H2,1-4H3,(H,12,16)
InChIKeyQPMAMINMUFVDPD-UHFFFAOYSA-N
XLogP-0.83
TPSA78.67 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms16
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500230.31
LogP ≤ 5-0.83
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyl_hydrazine', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[(5-hydrazinyl-5-oxopentan-2-yl)-propylamino]-N,N-dimethylacetamide
CID 63577903
2-[[1-(4-fluorophenyl)-1-oxopropan-2-yl]-propylamino]-N,N-dimethylacetamide
CID 62030734
ethyl 2-[[1-(butylamino)-1-oxopropan-2-yl]-propylamino]acetate
CID 62026762
2-[bis(2-methylpropyl)amino]propanehydrazide
CID 63585398
ethyl 2-[[1-oxo-1-(pentylamino)propan-2-yl]-propylamino]acetate
CID 62026570
2-[(1-hydrazinyl-3-methyl-1-oxobutan-2-yl)-propylamino]-N-methylacetamide
CID 55212881
2-[(1-amino-1-sulfanylidenepentan-3-yl)-propylamino]-N,N-dimethylacetamide
CID 54985350
2-[(4-hydrazinyl-4-oxobutan-2-yl)-methylamino]-N,N-dimethylacetamide
CID 63573657
methyl 2-[[1-(butylamino)-1-oxopropan-2-yl]-propylamino]acetate
CID 62010774
2-[(1-amino-1-oxopropan-2-yl)-propylamino]acetic acid
CID 61008085
2-[2-aminoethyl(propyl)amino]-N-propylpropanamide
CID 61349368
2-(dipropylamino)propanamide
CID 18474126

Frequently Asked Questions

What is the IUPAC name of 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide?
The IUPAC name of 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide (CID 63578798) is 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide.
What is the SMILES notation for 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide?
The canonical SMILES for 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide is CCCN(CC(=O)N(C)C)C(C)C(=O)NN.
What is the InChIKey of 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide?
The InChIKey is QPMAMINMUFVDPD-UHFFFAOYSA-N. The full InChI is InChI=1S/C10H22N4O2/c1-5-6-14(7-9(15)13(3)4)8(2)10(16)12-11/h8H,5-7,11H2,1-4H3,(H,12,16).
What are the key properties of 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide?
2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide has a molecular weight of 230.31 g/mol, XLogP of -0.83, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(1-hydrazinyl-1-oxopropan-2-yl)-propylamino]-N,N-dimethylacetamide is sourced from PubChem (CID 63578798), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).